Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 2Phase 4 2Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Intracranial Aneurysm 1Insulin Resistance 1Hypoglycemia 1Hyperglycemia 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 59Cyclophosphamide 44pembrolizumab 34Radiotherapy 30fludarabine 27Nivolumab 26Biopsy 26Metformin 22Fluorodeoxyglucose F18 22Specimen Handling 20Bevacizumab 20Temozolomide 17Radiosurgery 17Cisplatin 16Carboplatin 14Fluorouracil 13Dexamethasone 13Paclitaxel 12Gemcitabine 12Etoposide 12gallium 68 PSMA-11 11durvalumab 11X-Rays 11Surgical Procedures, Operative 11Radiation 11Positron Emission Tomography Computed Tomography 11Letrozole 11Irinotecan 11Ipilimumab 11Surveys and Questionnaires 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Insulin × Clear all
NCT03904199 2023-01-20

Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Completed
9 enrolled

Hyperglycemia

NCT00993057 2019-12-13

Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia

Northwestern University

Phase EARLY_PHASE1 Completed
120 enrolled
CNS

Brain Neoplasms, Intracranial Aneurysm, Hypoglycemia, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡